share_log

康哲藥業:(經修訂)截至二零二四年四月三十日止月份之股份發行人的證券變動月報表

CMS: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

Hong Kong Stock Exchange ·  May 7 07:21
Summary by Moomoo AI
康哲藥業控股有限公司(CMS)於2024年5月7日向香港交易及結算所有限公司重新提交了截至2024年4月30日的證券變動月報表。報告顯示,公司在2024年4月期間沒有增加或減少其法定/註冊股本,結存維持在20,000,000,000股,每股面值0.005美元,法定/註冊股本總額為100,000,000美元。此外,公司於2023年4月28日購回了12,460,000股普通股,但截至報告期末,這些股份尚未註銷。公司秘書吳三燕確認,所有證券的發行均已獲得董事會正式授權批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
康哲藥業控股有限公司(CMS)於2024年5月7日向香港交易及結算所有限公司重新提交了截至2024年4月30日的證券變動月報表。報告顯示,公司在2024年4月期間沒有增加或減少其法定/註冊股本,結存維持在20,000,000,000股,每股面值0.005美元,法定/註冊股本總額為100,000,000美元。此外,公司於2023年4月28日購回了12,460,000股普通股,但截至報告期末,這些股份尚未註銷。公司秘書吳三燕確認,所有證券的發行均已獲得董事會正式授權批准,並符合香港聯合交易所有限公司證券上市規則的相關要求。
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) RESUBMITTED ITS SECURITIES MONTH CHANGE REPORT FOR THE YEAR ENDED 30 APRIL 2024 WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED ON 7 MAY 2024. The report shows that the company did not increase or decrease its regulated/registered share capital during April 2024, maintaining a deposit of 20,000,000,000 shares with a face value of $0.005 per share and a total regulated/registered share capital of $100,000,000. In addition, the company repurchased 12,460,000 shares of ordinary shares on April 28, 2023, but as of the end of the reporting period, these shares have not been written off. Company Secretary Wu Sanyan confirmed that all issues of securities have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
CONGE PHARMACEUTICAL HOLDINGS LIMITED (CMS) RESUBMITTED ITS SECURITIES MONTH CHANGE REPORT FOR THE YEAR ENDED 30 APRIL 2024 WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED ON 7 MAY 2024. The report shows that the company did not increase or decrease its regulated/registered share capital during April 2024, maintaining a deposit of 20,000,000,000 shares with a face value of $0.005 per share and a total regulated/registered share capital of $100,000,000. In addition, the company repurchased 12,460,000 shares of ordinary shares on April 28, 2023, but as of the end of the reporting period, these shares have not been written off. Company Secretary Wu Sanyan confirmed that all issues of securities have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more